Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th1/Th2 balance in acute lymphoblastic leukemia in children

Archivum Immunologiae et Therapiae Experimentalis

Volumn 53, Issue 4, 2005, Pages 357-363

  Łuczyński, Włodzimierz ^a   Stasiak Barmuta, Anna ^a   Krawczuk Rybak, Maryna ^a   Malinowska, Iwona ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cancer; Co stimulatory molecules; IFN ; IL 4; Immunosuppression

Indexed keywords

ASPARAGINASE; CD28 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DAUNORUBICIN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; CANCER COMBINATION CHEMOTHERAPY; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LEUKEMIA REMISSION; MALE; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANTIGENS, CD28; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-4; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; PREDNISONE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 31944444896     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Banks R. E., Gearing A. J., Hemingway I. K., Norfolk D. R., Perren T. J. and Selby P. J. (1993): Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular adhesion molecule (VCAM-1) in human malignancies. Br. J. Cancer, 68, 122-124.
2. Bruserud O., Ulvestad E., Halstensen A., Berentsen S., Bergheim J. and Nesthus I. (1997): Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia. Eur. J. Haematol., 59, 269-276.
3. + T-cell subset in B-cell chronic lymphocytic leukaemia. Br. J. Haematol., 104, 589-599.
4. Frydecka I., Kosmaczewska A., Bocko D., Ciszak L., Wolowiec D., Kuliczkowski K. and Kochanowska I. (2004): Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia. Br. J. Cancer, 90, 2042-2048.
5. Kamińska T., Hus I., Dmoszyńska A. and Kandefer- Szerszeń M. (2001): Cytokine production in whole blood cell cultures of patients with B-lineage acute lymphoblastic leukemia. The influence of granulocyte-macrophage colony-stimulating factor. Arch. Immunol. Ther. Exp., 49, 71-77.
6. + T cells from B-CLL patients: impact on clonal B-cell apoptosis. Br. J. Haematol., 112, 760-767.
7. Lee P. P., Zeng D., McCaulay A. E., Chen Y.-F., Geiler C., Umetsu D. T. and Chao N. J. (1997): T helper 2-dominant antilymphoma immune response is associated with fatal outcome. Blood, 90, 1611-1617.
8. + T lymphocytes in infectious mononucleosis caused by Ebstein-Barr virus infection. Clin. Exp. Immunol., 133, 384-390.
9. Łuczyński W., Stasiak-Barmuta A., Muszyńska- Rosłan K., Krawczuk-Rybak M. and Kasprzycka E. (2002): T-cell and monocyte activation during infection in children with neoplastic disease [Aktywacja limfocytów T i monocytów w przebiegu infekcji u dzieci z choroba̧ nowotworowa̧]. Med. Wieku Rozwoj., 6, 31-41.
10. Manocha S., Matrai Z., Osthoff M., Carter A. and Pettitt A. R. (2003): Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia. Leuk. Lymphoma, 44, 797-800.
11. 1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model. Cancer Immunol. Immunother., 50, 588-596.
12. 2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma. Cancer Immunol. Immunother., 50, 566-568.
13. Ohga S., Nomura A., Takada H., Ihara K., Kawakami K., Yanai F., Takahata Y., Tanaka T., Kasuga N. and Hara T. (2001): Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J. Infect. Dis., 183, 1-7.
14. Papasavvas E., Sandberg J. K., Rutstein R., Moore E. C., Mackiewicz A., Thiel B., Pistilli M., June R. R., Jordan K. A., Gross R., Maino V. C., Nixon D. F. and Montaner L. J. (2003): Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression. J. Infect. Dis., 188, 873-882.
15. Pui C. H., Luo X., Evans W., Martin S., Rugg A., Wiliams J., Crist W. M. and Hudson M. (1993): Serum intercellular adhesion molecule-1 in childhood malignancy. Blood, 82, 895-898.
16. + normal T cells. Br. J. Haematol., 117, 59-69.
17. Scrivener S., Kaminski E. R., Demaine A. and Prentice A. G. (2001): Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation. Br. J. Haematol., 112, 959-964.
18. + T cell population. Microbiol. Immunol., 44, 1011-1017.
19. Wołowiec D., Frydecka I., Kosmaczewska A., Boćko D., Ciszak L., Urbaniak-Kujda D., Kapelko-Słowik K., Kuliczkowski K. and Kochanowska I. (2003): IL-4 and IL-10 production by T cells in patients with B-cell chronic lymphocytic leukemia [Wydzielanie interleukiny 4 oraz interleukiny 10 przez limfocyty T chorych na przewlekła̧ białaczkȩ limfatyczna̧ B-komórkowa̧]. Adv. Clin. Exp. Med., 12, 45-49.
20. Zhang X. L., Komada Y., Chipeta J., Li Q.-S., Inaba H., Azuma E., Yamamoto H. and Sakurai M. (2000): Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunol. Immunother., 49, 165-172.